Arrowhead Pharmaceuticals Inc increased IV. Quarter net loss per share of $-0.81 compare to net loss per share of $-0.61 recorded in the same quarter a year ago a decrease compare to $-0.68 realized in previous quarter.
IV. Quarter
Earnings Per Share
Revenues
$ -0.81
$
32 Mill
$-0.20
$-7M-17.52 %
Arrowhead Pharmaceuticals Inc 's Revenue
fell by
-17.52 % in IV. Quarter (Sep 30 2022) year on year,
to $32 million and
declined by
-2.58 % sequentially.
Arrowhead Pharmaceuticals Inc is Expected to report next financial results on May 09, 2023.
Arrowhead Pharmaceuticals Inc 's
in IV. Quarter recorded net loss of $-85.942 million, an increase from net loss of $-63.374 million in IV. Quarter a year ago.
In IV. Quarter company's net cash and cash equivalents decreased by $-31 million, capital expenditures fell by 298.96%, to $-33 millions compare to same quarter a year ago and fell by 243.03% from III. Quarter (Jun 30 2022).
